HMGB1 and cancer: Furthermore, they depicted that PCCs utilize HMGB1 endogenously as a pro-autophagic protein augmenting cancer cell survival and preventing programmed apoptotic cell death via dislocation of Bcl-2 from Beclin-1 [41].